HIGHLIGHTS
- who: Weitao Wang et al. from the Guangxi University of Chinese Medicine, Nanning, China have published the Article: Network Pharmacology and Molecular Docking to Explore the Mechanism of Kangxian Decoction for Epilepsy, in the Journal: Evidence-Based Complementary and Alternative Medicine
- what: The aim of this study was to explore the active components of KXD and clarify its antiepileptic mechanism through network pharmacology and molecular docking. The authors explored the possibility that KXD for epilepsy may act on multiple targets through multiple active ingredients involving neurotransmitters and neuroinflammatory pathways providing a theoretical basis for subsequent . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.